Edesa Biotech, Inc. Recorded Big Gain

Edesa Biotech, Inc. (EDSA:NASDAQ) rocketted at $11.92, a gain of 102.7%. On Fri, Sep 17, 2021, EDSA:NASDAQ touched a New 2-Week Intraday High of $6.09. The stock got featured on our News Catalysts scanner on Mon, Sep 20, 2021 at 04:48 PM in the 'BIOTECH' category. From Fri, Sep 03, 2021, the stock recorded 44.44% Up Days and 50.00% Green Days
The stock spiked on Tue, May 04, 2021 at $7.22 with a volume of 1M+, and its share price has been moving sideways in recent weeks.
About Edesa Biotech, Inc. (EDSA:NASDAQ)
Stellar Biotechnologies Inc is a biotechnology company. The company is engaged in the aquaculture, research, and development, manufacture, and commercialization of Keyhole Limpet Hemocyanin (KLH). KLH is an immune-stimulating protein with an extensive history of safe and effective use in immunological applications. KLH can be used as an active pharmaceutical ingredient (API) and combined with a disease-targeting agent to create immunotherapies for the treatment of a variety of diseases. It derives its revenues mostly from Europe. Stellar primarily market and distribute products directly to biotechnology and pharmaceutical companies, academic institutions, clinical research organizations, and research centers.
Top 10 Gainers:
- Edesa Biotech, Inc. (EDSA:NASDAQ), 102.72%
- BLNG (BLNG:NASDAQ), 100%
- ARQQ (ARQQ:NASDAQ), 36.58%
- SNTG (SNTG:NASDAQ), 28.8%
- BROS (BROS:NYSE), 18.39%
- DRMA (DRMA:NASDAQ), 16.79%
- Corvus Pharmaceuticals, Inc. (CRVS:NASDAQ), 15.98%
- UCL (UCL:NASDAQ), 14.1%
- Synlogic, Inc. (SYBX:NASDAQ), 12.77%
- SRNG (SRNG:NASDAQ), 12.73%